Anticipatory compounding of controlled substances may seem like a simple operational efficiency—but it sits in a tricky regulatory space where FDA and DEA expectations don’t always align.
In this Quick Take from Rxpert Solutions, we break down what hospital pharmacies need to know to stay compliant while maintaining safe and efficient sterile compounding practices.
You’ll learn:
- How FDA and DEA interpretations differ
- Why documentation and clear internal policies are essential
- What your pharmacy must have in place before batching IVs
- Practical guidance for directors, compliance officers, and sterile compounding teams
Short, focused, and actionable—this episode gives you the clarity you need to navigate this regulatory gray zone with confidence.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=quick_take&utm_campaign=anticipatory_compounding
